474 results on '"El-Chami, Mikhael F."'
Search Results
2. Electrocardiographic predictors of atrial mechanical sensing in leadless pacemakers
3. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial
4. Managing superior vena cava syndrome in patients with cardiac implantable electronic device leads: Strategies and considerations
5. A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: 12-Month results from the Micra AV post-approval registry
6. Accurate detection of lead malfunction from ECG-derived bipolar pacing stimulus amplitude
7. Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare population
8. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association
9. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association
10. Safety of same-day discharge after lead extraction procedures
11. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
12. Abstract 17552: Pre-Existing Right Ventricular Lead Performance After Transcatheter Tricuspid Valve Replacements (TTVR)?
13. Abstract 14849: Impact of Intravenous Heparin Bolus on Outcomes of Leadless Pacemaker Implantation
14. Abstract 14021: Micra VR Leadless vs. Single-Chamber Transvenous Pacing Outcomes in the Medicare Advantage Population
15. Abstract 14011: Micra AV Leadless vs. Dual-Chamber Transvenous Pacing Outcomes Among Patients With End-Stage Renal Disease in the Medicare Population
16. Abstract 12244: Gender Differences in Leadless Pacemaker Peri-Procedural Adverse Events, Long-Term Device Functions, and Clinical Outcomes
17. Septal Bipolar Ablation to Prevent Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Implantation
18. The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease
19. Leadless Pacing: Where We Currently Stand and What the Future Holds
20. Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study
21. Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study
22. Temporal trends of device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients with underlying kidney disease
23. Diagnostic Pacing Maneuvers for Supraventricular Tachycardia Discrimination: a Taxonomic Approach
24. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
25. Chronic kidney disease and transvenous cardiac implantable electronic device infection—is there an impact on healthcare utilization, costs, disease progression, and mortality?
26. Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients
27. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
28. Abstract 13416: Evaluation of Risk Factors for Pacemaker After Tavr Among Patients With a Pre-Existing Right Bundle Branch Block
29. Abstract 13220: Real-World Analysis of the Electrical Performance and Projected Longevity of Leadless Ventricular Pacemakers
30. Abstract 12195: Accurate Detection of Lead Malfunction Based on Ekg-Derived Bipolar Pacing Stimulus Amplitude
31. Abstract 10532: Physician Interpretation and Characterization of Intracardiac Electrograms at the Time of Non-Cardiac Death
32. A Predictive Model for the Long-Term Electrical Performance of a Leadless Transcatheter Pacemaker
33. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke
34. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker
35. 1-Year Prospective Evaluation of Clinical Outcomes and Shocks: The Subcutaneous ICD Post Approval Study
36. Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation.
37. Outcomes of tricuspid regurgitation after lead extraction.
38. Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
39. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study
40. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms
41. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: An Analysis of All Appropriate Therapy in the PRAETORIAN trial
42. Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results
43. Comparison of echocardiographic and fluoroscopic sizing of the left atrial appendage prior to percutaneous closure
44. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology
45. Long-term performance of a pacing lead family: A single-center experience
46. Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker
47. Recurrence of new-onset post-operative AF after cardiac surgery detected by implantable loop recorders: A systematic review and Meta-analysis
48. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
49. Gender Differences With Leadless Pacemakers: Periprocedural Complications, Long-Term Device Function, and Clinical Outcomes
50. Abstract 15562: Incidence and Risk Factors of Device-related Infection in De Novo Transvenous Implantable Cardiac Defibrillator Medicare Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.